OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Development of antifibrotic therapy for stricturing Crohn’s disease: lessons from randomized trials in other fibrotic diseases
Sinan Lin, Ren Mao, Chenchen Qian, et al.
Physiological Reviews (2021) Vol. 102, Iss. 2, pp. 605-652
Open Access | Times Cited: 49
Sinan Lin, Ren Mao, Chenchen Qian, et al.
Physiological Reviews (2021) Vol. 102, Iss. 2, pp. 605-652
Open Access | Times Cited: 49
Showing 26-50 of 49 citing articles:
MiRNA-Based Therapies for the Treatment of Inflammatory Bowel Disease: What Are We Still Missing?
Tommaso Innocenti, Elisabetta Bigagli, Erica Nicola Lynch, et al.
Inflammatory Bowel Diseases (2022) Vol. 29, Iss. 2, pp. 308-323
Closed Access | Times Cited: 10
Tommaso Innocenti, Elisabetta Bigagli, Erica Nicola Lynch, et al.
Inflammatory Bowel Diseases (2022) Vol. 29, Iss. 2, pp. 308-323
Closed Access | Times Cited: 10
P2X7 Receptor Regulates Collagen Expression in Human Intestinal Fibroblasts: Relevance in Intestinal Fibrosis
L Lis-López, C Bauset, Marta Seco-Cervera, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12936-12936
Open Access | Times Cited: 5
L Lis-López, C Bauset, Marta Seco-Cervera, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12936-12936
Open Access | Times Cited: 5
Preventing fibrosis in IBD: update on immune pathways and clinical strategies
Jie Wang, Bo Yang, Jyotsna Chandra, et al.
Expert Review of Clinical Immunology (2024) Vol. 20, Iss. 7, pp. 727-734
Closed Access | Times Cited: 1
Jie Wang, Bo Yang, Jyotsna Chandra, et al.
Expert Review of Clinical Immunology (2024) Vol. 20, Iss. 7, pp. 727-734
Closed Access | Times Cited: 1
Effectiveness comparison between ustekinumab and infliximab for Crohn’s disease complicated with intestinal stenosis: a multicenter real-world study
Xidong He, Yufang Wang, Jingyao Sun, et al.
Therapeutic Advances in Gastroenterology (2024) Vol. 17
Open Access | Times Cited: 1
Xidong He, Yufang Wang, Jingyao Sun, et al.
Therapeutic Advances in Gastroenterology (2024) Vol. 17
Open Access | Times Cited: 1
Macrophages in intestinal fibrosis and regression
Hui Yao, Guoyao Tang
Cellular Immunology (2022) Vol. 381, pp. 104614-104614
Closed Access | Times Cited: 7
Hui Yao, Guoyao Tang
Cellular Immunology (2022) Vol. 381, pp. 104614-104614
Closed Access | Times Cited: 7
Contemporary Imaging Assessment of Strictures and Fibrosis in Crohn Disease, With Focus on Quantitative Biomarkers: From the AJR Special Series on Imaging of Fibrosis
Jordi Rimola, K Beek, Íngrid Ordás, et al.
American Journal of Roentgenology (2023) Vol. 222, Iss. 4
Closed Access | Times Cited: 3
Jordi Rimola, K Beek, Íngrid Ordás, et al.
American Journal of Roentgenology (2023) Vol. 222, Iss. 4
Closed Access | Times Cited: 3
Identification of the novel role of sterol regulatory element binding proteins (SREBPs ) in mechanotransduction and intraocular pressure regulation
Ting Wang, Avinash Soundararajan, Jeffrey Rabinowitz, et al.
The FASEB Journal (2023) Vol. 37, Iss. 11
Open Access | Times Cited: 3
Ting Wang, Avinash Soundararajan, Jeffrey Rabinowitz, et al.
The FASEB Journal (2023) Vol. 37, Iss. 11
Open Access | Times Cited: 3
Integrating new and emerging therapies into inflammatory bowel disease clinical practice
Shaina Sekhri, Andrés Yarur
Current Opinion in Gastroenterology (2022) Vol. 38, Iss. 4, pp. 328-336
Closed Access | Times Cited: 5
Shaina Sekhri, Andrés Yarur
Current Opinion in Gastroenterology (2022) Vol. 38, Iss. 4, pp. 328-336
Closed Access | Times Cited: 5
The Effects of Mesenteric Inflammation on Intestinal Fibrosis
Ren Mao, Zishan Liu, Florian Rieder
Springer eBooks (2023), pp. 149-163
Closed Access | Times Cited: 2
Ren Mao, Zishan Liu, Florian Rieder
Springer eBooks (2023), pp. 149-163
Closed Access | Times Cited: 2
Advanced machine learning model for predicting Crohn's disease with enhanced ant colony optimization
Xixi He, Huajun Ye, Rui Zhao, et al.
Computers in Biology and Medicine (2023) Vol. 163, pp. 107216-107216
Closed Access | Times Cited: 2
Xixi He, Huajun Ye, Rui Zhao, et al.
Computers in Biology and Medicine (2023) Vol. 163, pp. 107216-107216
Closed Access | Times Cited: 2
Resistance to apoptosis in complicated Crohn's disease: Relevance in ileal fibrosis
Marta Seco-Cervera, D Ortiz‐Masiá, Dulce C. Macias-Ceja, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1870, Iss. 2, pp. 166966-166966
Open Access | Times Cited: 2
Marta Seco-Cervera, D Ortiz‐Masiá, Dulce C. Macias-Ceja, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1870, Iss. 2, pp. 166966-166966
Open Access | Times Cited: 2
An emerging view on vascular fibrosis molecular mediators and relevant disorders: from bench to bed
Rongxuan Hua, Han Gao, Chengwei He, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 2
Rongxuan Hua, Han Gao, Chengwei He, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 2
Collagen remodeling in inflammatory bowel disease
Joachim Høg Mortensen, Martin Pehrsson, M.A. Karsdal, et al.
Elsevier eBooks (2024), pp. 483-494
Closed Access
Joachim Høg Mortensen, Martin Pehrsson, M.A. Karsdal, et al.
Elsevier eBooks (2024), pp. 483-494
Closed Access
O impacto dos imunobiológicos no prognóstico de pacientes com Doença de Crohn
Isadora Nascimento dos Santos, Kamila Kivia Rosa Batista, Larissa de Alcântara Gonçalves Ferreira Pinto, et al.
Brazilian Journal of Health Review (2024) Vol. 7, Iss. 2, pp. e68244-e68244
Open Access
Isadora Nascimento dos Santos, Kamila Kivia Rosa Batista, Larissa de Alcântara Gonçalves Ferreira Pinto, et al.
Brazilian Journal of Health Review (2024) Vol. 7, Iss. 2, pp. e68244-e68244
Open Access
New targeted pharmacotherapy and experimental therapies for inflammatory bowel disease
Saroj Kanta Sahu, Suprabhat Giri, Preetam Nath, et al.
Journal of Integrative Medicine and Research (2024) Vol. 2, Iss. 3, pp. 127-136
Closed Access
Saroj Kanta Sahu, Suprabhat Giri, Preetam Nath, et al.
Journal of Integrative Medicine and Research (2024) Vol. 2, Iss. 3, pp. 127-136
Closed Access
Anti-fibrotics in inflammatory bowel diseases: Challenges and successes
Gaurav Chauhan, William J. Massey, Ido Veisman, et al.
Advances in pharmacology (2024), pp. 85-106
Closed Access
Gaurav Chauhan, William J. Massey, Ido Veisman, et al.
Advances in pharmacology (2024), pp. 85-106
Closed Access
The landscape of new therapeutic opportunities for IBD
Andres Hurtado‐Lorenzo, Jennifer L Swantek
Advances in pharmacology (2024), pp. 1-83
Closed Access
Andres Hurtado‐Lorenzo, Jennifer L Swantek
Advances in pharmacology (2024), pp. 1-83
Closed Access
Dual activation of GCGR/GLP1R signaling ameliorates intestinal fibrosis via metabolic regulation of histone H3K9 lactylation in epithelial cells
Han Liu, Yujie Hong, Hui Chen, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 15, Iss. 1, pp. 278-295
Open Access
Han Liu, Yujie Hong, Hui Chen, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 15, Iss. 1, pp. 278-295
Open Access
Endoskopische und chirurgische Behandlung intestinaler Stenosen im Zusammenhang mit chronisch-entzündlichen Darmerkrankungen
Tabea Pfister, Jonas Zbinden, Benjamin Misselwitz, et al.
Schweizer Gastroenterologie (2024)
Open Access
Tabea Pfister, Jonas Zbinden, Benjamin Misselwitz, et al.
Schweizer Gastroenterologie (2024)
Open Access
Myeloid‐Derived Suppressor Cell Accumulation Drives Intestinal Fibrosis through mCCL6/hCCL15 Chemokine‐Mediated Fibroblast Activation
Xiaohui Cheng, Pingwen Shao, X.Y. Wang, et al.
Advanced Science (2024)
Open Access
Xiaohui Cheng, Pingwen Shao, X.Y. Wang, et al.
Advanced Science (2024)
Open Access
The Promise of Single-Cell RNA Sequencing to Redefine the Understanding of Crohn’s Disease Fibrosis Mechanisms
Iona Campbell, Michael Glinka, Fadlo Shaban, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 12, pp. 3884-3884
Open Access | Times Cited: 1
Iona Campbell, Michael Glinka, Fadlo Shaban, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 12, pp. 3884-3884
Open Access | Times Cited: 1
Understanding progression of strictures in ileal Crohn's disease—The importance of setting methodological standards
Helena Tavares de Sousa, Fátima Carneiro
United European Gastroenterology Journal (2022) Vol. 10, Iss. 9, pp. 915-916
Open Access | Times Cited: 2
Helena Tavares de Sousa, Fátima Carneiro
United European Gastroenterology Journal (2022) Vol. 10, Iss. 9, pp. 915-916
Open Access | Times Cited: 2
Identification of the novel role of sterol regulatory element binding proteins (SREBPs) in mechanotransduction and intraocular pressure regulation
Ting Wang, Avinash Soundararajan, Jeffery Rabinowitz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Ting Wang, Avinash Soundararajan, Jeffery Rabinowitz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Die IL36R-induzierbare Matrixmetalloproteinase 13 vermittelt intestinale Fibrose
Kristina Koop, Karin Enderle, Laura Ruspeckhofer, et al.
Zeitschrift für Gastroenterologie (2023)
Closed Access
Kristina Koop, Karin Enderle, Laura Ruspeckhofer, et al.
Zeitschrift für Gastroenterologie (2023)
Closed Access
